Autoinjectors Market Growth Outlook, Business Overview, Dynamics, Future Trends and COVID-19 Impact Analysis By 2030
Autoinjectors
Market Highlights
The Global Autoinjectors Market is Estimated
to be Valued at USD 3.4 Billion by 2024 and is Expected to Register a CAGR of 18.2%
During the Forecast Period 2022 – 2030. The global autoinjectors market is studied in detail in the report, including
the key drivers and restraints affecting the market’s growth, the leading
players operating in the global autoinjectors market, and the leading segments
likely to dominate the global autoinjectors market over the forecast period.
Autoinjectors are spring-loaded syringes
designed for easy administration upon oneself or by an untrained person on the
patient. The key intention behind the manufacturing of autoinjectors is to make
the process of injecting the respective drug safer and easier to perform, so
that untrained personnel can also do it in case of emergencies. The growing
prevalence of chronic diseases such as diabetes and the growing preference
among patients for home care solutions for the same is likely to be a major
driver for the global autoinjectors market over the forecast period. Insulin
injections for diabetes management have to be administered regularly, which may
lead to the patient having to come into the hospital every time s/he needs an
injection, which can be taxing for people living far away. Growing demand for
home-based care and management when dealing with long-term diseases such as
diabetes is likely to propel the global autoinjectors market over the forecast
period.
The growing prevalence of allergies and
subsequent cases of anaphylaxis is also likely to be a major driver for the
global autoinjectors market, as autoinjectors are majorly used for injecting
epinephrine in case of anaphylaxis.
Segment Analysis
The Global Autoinjectors Market has been
segmented on the basis of product type, design therapeutic application,
distribution channel, and region. On the basis of product type, the market has
been divided into the disposable autoinjectors and reusable autoinjectors. The
disposable autoinjectors segment held the majority market share in 2018. It
also was the fastest-growing owing to the increasing demand for testing new
drugs and chemicals and vigorous growth in the pharmaceutical and
biopharmaceutical sectors.
Regional Analysis
Geographically, the global autoinjectors market report has been segmented into North America,
Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis,
the Americas was the largest market for the autoinjectors in 2018 and is
expected to remain dominant during the review period. Europe accounted for a
significant market share and is projected to be the second-largest market
during the forecast period. The well-established healthcare infrastructure,
technology advancement, and innovation in drug delivery systems, and rising
prevalence of anaphylaxis incidences, diabetes, and cancer are driving the
growth of the autoinjectors market in the region. Germany accounted for the
largest market share of 24.7% in 2018, and the country-level market is
projected to register a CAGR of 15.84% during the forecast period.
Market Players
Market Research Future (MRFR) recognizes Amgen
Inc. (US), Becton, Dickinson and Company (US), AbbVie Inc. (US), Mylan N.V.
(US), Eli Lilly and Company (US), Ypsomed (Switzerland), Owen Mumford Ltd (UK),
Consort Medical (UK), SHL Group (Taiwan), Johnson & Johnson Services Inc.
(US), Teva Pharmaceutical Industries Ltd (Israel), Antares Pharma (US) as the
key players in the Global Autoinjectors Market.
About Market
Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment